» Articles » PMID: 18989780

Expression of Alkaline Sphingomyelinase in Yeast Cells and Anti-inflammatory Effects of the Expressed Enzyme in a Rat Colitis Model

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 2008 Nov 8
PMID 18989780
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Alkaline sphingomyelinase (Alk-SMase) is a key enzyme in the intestinal tract for digestion of dietary sphingomyelin (SM), which generates lipid messengers with cell-cycle regulating effects. The enzyme is significantly decreased in ulcerative colitis and colon cancer. Based on this information, we wanted to investigate whether the enzyme had preventive effects against murine colitis. We report herein a method to express a biologically active Alk-SMase from Pichia pastoris yeast cells. By using the expressed enzyme to treat a rat colitis model induced by dextran sulfate sodium, we found that intrarectal instillation of Alk-SMase once daily for 1 week significantly reduced the inflammation score and protected the colonic epithelium from inflammatory destruction. We found a tendency for decreased tumor necrosis factor (TNF)-alpha expression in the Alk-SMase-treated group. This study, for the first time, provides a method to produce the enzyme and shows the potential applicability of the enzyme in the treatment of inflammatory bowel diseases.

Citing Articles

From Classical to Alternative Pathways of 2-Arachidonoylglycerol Synthesis: AlterAGs at the Crossroad of Endocannabinoid and Lysophospholipid Signaling.

Briand-Mesange F, Gennero I, Salles J, Trudel S, Dahan L, Ausseil J Molecules. 2024; 29(15).

PMID: 39125098 PMC: 11314389. DOI: 10.3390/molecules29153694.


Alkaline sphingomyelinase deficiency impairs intestinal mucosal barrier integrity and reduces antioxidant capacity in dextran sulfate sodium-induced colitis.

Tian Y, Li X, Wang X, Pei S, Pan H, Cheng Y World J Gastroenterol. 2024; 30(10):1405-1419.

PMID: 38596488 PMC: 11000083. DOI: 10.3748/wjg.v30.i10.1405.


Alkaline sphingomyelinase (NPP7) impacts the homeostasis of intestinal T lymphocyte populations.

Alyamani M, Kadivar M, Erjefalt J, Johansson-Lindbom B, Duan R, Nilsson A Front Immunol. 2023; 13:1050625.

PMID: 36741374 PMC: 9894718. DOI: 10.3389/fimmu.2022.1050625.


Transcriptome analysis of intestine from alk-SMase knockout mice reveals the effect of alk-SMase.

Zhu J, Wang L, Guo Z, Zhang T, Zhang P Cancer Cell Int. 2022; 22(1):344.

PMID: 36348490 PMC: 9644495. DOI: 10.1186/s12935-022-02764-y.


Transcriptome analysis alk-SMase knockout mice reveals the effect of alkaline sphingomyelinase on liver.

Zhu J, Wang L, Li X, Lan D, Song L, Li Y Biochem Biophys Rep. 2022; 30:101240.

PMID: 35360085 PMC: 8961189. DOI: 10.1016/j.bbrep.2022.101240.


References
1.
Possemiers S, Van Camp J, Bolca S, Verstraete W . Characterization of the bactericidal effect of dietary sphingosine and its activity under intestinal conditions. Int J Food Microbiol. 2005; 105(1):59-70. DOI: 10.1016/j.ijfoodmicro.2005.05.007. View

2.
Sjoqvist U, Hertervig E, Nilsson A, Duan R, Ost A, Tribukait B . Chronic colitis is associated with a reduction of mucosal alkaline sphingomyelinase activity. Inflamm Bowel Dis. 2002; 8(4):258-63. DOI: 10.1097/00054725-200207000-00004. View

3.
Cheng Y, Nilsson A, Tomquist E, Duan R . Purification, characterization, and expression of rat intestinal alkaline sphingomyelinase. J Lipid Res. 2002; 43(2):316-24. View

4.
Lundgren P, Nilsson A, Duan R . Distribution and properties of neutral ceramidase activity in rat intestinal tract. Dig Dis Sci. 2001; 46(4):765-72. DOI: 10.1023/a:1010792031910. View

5.
STOFFEL W . Chemical synthesis of choline-labeled lecithins and sphingomyelins. Methods Enzymol. 1975; 35:533-41. DOI: 10.1016/0076-6879(75)35181-1. View